Company Valuation: Immunovia AB

Data adjusted to current consolidation scope
Fiscal Period: December 2021 2022 2024 2025 2026 2027 2028
Market Cap 1 1,697 595.2 92.66 152.7 134.5 - -
Change - -64.93% - 64.79% -11.89% - -
Enterprise Value (EV) 1 1,443 526.7 92.66 76.09 67.53 60.53 116.5
Change - -63.5% - -17.88% -11.25% -10.37% 92.51%
P/E -0.11x -0.04x -0.01x -0.54x -2x -5x -10x
PBR 0.04x 0.02x - - - - -
PEG - -0.01x - 0x 0x 0.1x 0.2x
Capitalization / Revenue 1,775x 494x - 203x 42x 7.78x 2.45x
EV / Revenue 1,510x 437x - 101x 21.1x 3.5x 2.12x
EV / EBITDA -9.78x -3.17x - -0.97x -0.76x -0.76x -2.48x
EV / EBIT -8.66x -2.76x - -0.95x -0.74x -0.74x -2.33x
EV / FCF -9.27x -2.97x - -0.91x -0.72x -0.7x -2.08x
FCF Yield -10.8% -33.6% - -110% -139% -144% -48.1%
Dividend per Share 2 - - - - - - -
Rate of return - - - - - - -
EPS 2 -689 -743 -93 -0.42 -0.1 -0.04 -0.02
Distribution rate - - - - - - -
Net sales 1 0.956 1.204 - 0.752 3.2 17.3 55
EBITDA 1 -147.6 -166.2 - -78.06 -89 -80 -47
EBIT 1 -166.6 -191.2 - -80.38 -91 -82 -50
Net income 1 -156 -168.1 -76.54 -145.9 -91 -82 -50
Net Debt 1 -254.1 -68.47 - -76.6 -67 -74 -18
Reference price 2 75.0000 26.3000 0.5460 0.2270 0.2000 0.2000 0.2000
Nbr of stocks (in thousands) 22,632 22,632 169,711 672,667 672,667 - -
Announcement Date 17/02/22 23/02/23 25/02/25 24/02/26 - - -
1SEK in Million2SEK
Estimates

P/E, Detailed evolution

P/E (Y) EV / Sales (Y) EV / EBITDA (Y) Dividend Yield (Y) Capi.($)
55.92x4.59x15.32x0.39% 15.63B
36.59x - - 2.21% 1.57B
18.56x2.67x8.97x2.12% 1.12B
-8.54x1.19x5.22x-.--% 932M
54.21x - - 0.83% 554M
45.29x - - - 444M
18.55x2.61x11.17x1.84% 382M
22.49x3.95x13.3x2.01% 341M
Average 30.38x 3.00x 10.80x 1.34% 2.62B
Weighted average by Cap. 48.12x 4.25x 14.30x 0.67%

Y-o-Y evolution of P/E

Historical PBR trend

Evolution Enterprise Value / Sales

Change in Enterprise Value/EBITDA

-40%: Exceptional extension
d
:
:
SEIZE THE OFFER!